Delivery Order SPE2DB22D1103-SPE2DB25FTHF4
Award Date
3/14/25
Potential Completion Date
4/4/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order is for the supply of ORGOVYX 120 MG TABLET medical products. The contract has an ultimate completion date of March 12, 2025 and was awarded on February 19, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order is for the pharmaceutical product ORGOVYX 120 MG TABLET UU 30S. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order is for the supply of ORGOVYX 120 MG TABLET UU 30S, a prescription medication. The contract has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, with ID SPE2DB20D1110|SPE2DB25FJ96K, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm-fixed-price delivery order is for ORGOVYX 120 MG TABLET UU 30S, with a period of performance through March 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,375.85 Firm Fixed Price Delivery Order is for the supply of ORGOVYX 120 MG TABLET, a pharmaceutical product, with a period of performance through January 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order contract, awarded on February 19, 2025, is for the supply of ORGOVYX 120 MG TABLET medication with a performance period through March 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order (SPE2DB22D3010|SPE2DB25FP1RL) is for the pharmaceutical product ORGOVYX 120 MG TABLET UU 30S. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,375.85 firm fixed-price delivery order contract is for the supply of ORGOVYX 120 MG TABLET. The contract has an ultimate completion date of February 4, 2025 and is not designated as a set-aside requirement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with the ID SPE2DB22D1017|SPE2DB25FF4PF, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,156.56 firm fixed-price delivery order is for the supply of ORGOVYX 120 MG TABLET, a pharmaceutical product, to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $1,385.52 with a firm fixed price. The award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply ORGOVYX 120 MG TABLET medication. The contract has an ultimate completion date of April 4, 2025 and was awarded on March 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...